AI assistant
NORTHROP GRUMMAN CORP /DE/ — Director's Dealing 2019
Feb 15, 2019
29899_dirs_2019-02-15_1f65659e-3216-4036-b42b-a16f66b2da90.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NORTHROP GRUMMAN CORP /DE/ (NOC)
CIK: 0001133421
Period of Report: 2019-02-13
Reporting Person: CHESTON SHEILA C. (Corp. VP & General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-13 | Common Stock | M | 10440.8500 | $0.0000 | Acquired | 54136.3700 | Direct |
| 2019-02-13 | Common Stock | F | 4519.0000 | $0.0000 | Disposed | 49617.3700 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-13 | Restricted Performance Stock Rights | $ | A | 8075.8500 | Acquired | Common Stock (8075.8500) | Direct | |
| 2019-02-13 | Restricted Performance Stock Rights | $ | M | 10440.8500 | Disposed | Common Stock (10440.8500) | Direct | |
| 2019-02-13 | Restricted Stock Rights | $ | A | 2845.0000 | Acquired | Common Stock (2845.0000) | Direct |
Footnotes
F1: Shares expected to be issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/17/16 with a valuation of performance measurement period ("measurement period") that ended 12/31/18. RPSRs to be settled at 115% of target. The shares are anticipated to be distributed into the participant's account on February 14, 2019.
F2: Shares surrendered to issuer in payment of tax liability in connection with settlement of RPSRs in accordance with Rule 16b-3(e)
F3: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).
F4: The RPSRs acquired include (i) 1,361.85 vested RPSRs with respect to the measurement period ended 12/31/18 acquired due to settlement of the 2016 RPSRs held at 115% of the target award and (ii) 6,714 unvested RPSRs granted under the LTISP on 2/13/19 with a measurement period ending on 12/31/21.
F5: Total amount includes 10,440.85 vested RPSRs granted under the LTISP on 2/17/16 with a measurement period ending on 12/31/18; 6,714 RPSRs granted on 2/13/19 with a measurement period ending on 12/31/21; 5,171 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20; and 7,626 RPSRs granted on 2/17/17 with a measurement period ending on 12/31/19.
F6: Total amount includes 6,714 RPSRs granted on 2/13/19 with a measurement period ending on 12/31/21; 5,171 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20; and 7,626 RPSRs granted on 2/17/17 with a measurement period ending on 12/31/19.
F7: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/13/19 and will vest on 2/13/22.
F8: Total amount includes 2,845 RSRs granted under the LTISP on 2/13/19 that will vest on 2/13/22; 2,348 RSRs granted under the LTISP on 2/13/18 that will vest on 2/13/21; 3,189 RSRs granted under the LTISP on 2/17/17 that will vest on 2/17/20; and 4,120 RSRs granted under the LTISP on 2/17/16 that will vest on 2/17/19.